Abstracts

847 – Endothelial Colony-Forming Cells From People With HIV Display an Interferon Gene Signature

Background People with HIV (PWH) have an increased risk of cardiovascular disease (CVD), however, the underlying mechanisms are not fully understood. Endothelial dysfunction is central to CVD pathology. Endothelial colony-forming cells (ECFC) arise from endothelial progenitors isolated from whole blood and retain the donor’s phenotypic characteristics ex vivo. ECFC are increasingly used to study disease-specific…

846 – Cholesterol Synthesis Pathways in Monocyte-Derived Macrophages Link CMV and HIV to Atherosclerosis

Background Cytomegalovirus (CMV) is a widespread herpesvirus associated with inflammation and inflammation-related disorders, including cardiovascular disease (CVD). Among people with HIV (PWH), who have a two-fold increase in CVD risk compared to people without HIV (PWoH), latent CMV is nearly universal, and CMV reactivation from latency occurs more frequently, but if and how CMV reactivation contributes…

822 – Social Determinants of Health and the Hypertension Care Cascade in a National HIV Cohort

Background HTN remains a leading modifiable risk factor for cardiovascular, cerebrovascular, and chronic kidney diseases, all disproportionately affecting people with HIV (PWH). Disparities in HTN care have been described in the general population, though such data is limited in PWH. We apply the care cascade framework to HTN to evaluate the association between personal and…

850 – Statin Effect Heterogeneity on Plaque Volume and Composition in the REPRIEVE Mechanistic Substudy

Background REPRIEVE and its Mechanistic Substudy established that pitavastatin prevents major adverse cardiovascular events and reduces noncalcified coronary plaque (NCP) on coronary CT angiography (CTA) among PWH with low-to-moderate traditional ASCVD risk. Here we assess heterogeneity of pitavastatin effects on NCP (density <350 HU) volume and plaque composition, categorized by density (<130HU fibrofatty, 130-350 HU fibrous, >350…

852 – Low-Density Lipoprotein Changes in People With HIV Initiating Statins for Primary Prevention

Background Statin use will likely increase in persons with HIV (PWH) at low-to-moderate CVD risk given the cardiovascular disease (CVD) prevention benefit demonstrated by the REPRIEVE trial. However, real-world benefit of statins may be lower than expected with insufficient low-density lipoprotein (LDL) reductions. Older studies reported that few PWH on statins experienced timely LDL reductions,…

833 – Prediction of Cardiovascular Risk Among PWH: Comparing the PREVENT and Pooled Cohort Equations

Background People with HIV (PWH) are at elevated cardiovascular disease (CVD) risk. Traditional risk prediction tools underestimate CVD risk among PWH and do not predict risk of heart failure (HF). The American Heart Association (AHA) developed new risk prediction equations, Predicting Risk of cardiovascular disease EVENTs (PREVENT), which include risk of HF and has not…

836 – Agrarian Diet Intervention Improves Metabolic Health in Men With HIV Who Have Sex With Men

Background People living with HIV (PLWH) suffer from increased incidence of metabolic disease and chronic systemic inflammation, even with effective Antiretroviral therapy (ART). Prevotella-rich, Bacteroides-poor (PRBP) microbiomes are commonly found in men who have sex with men (MSM), which make up a large portion of PLWH in the United States. A high-fiber agrarian diet (AD)…

841 – Markers of Arterial Stiffness in People Living With HIV and Echocardiographic Outcomes

Background Cardiovascular disease is a growing cause of morbidity and mortality in people living with HIV (PLWH). Arterial stiffness may be an intermediary between HIV-infection and CVD, necessitating holistic assessment of arterial stiffness and correlation with cardiac outcomes. We conducted a cross-sectional study of PLWH and HIV-uninfected community controls using multimodal assessment of arterial stiffness…

837 – Decreased Anti-Inflammatory Tryptophan Metabolites Correlate With Higher CVD Risk in PWH

Background Distinct inflammatory profiles have been associated with increased prevalence of cardiovascular disease (CVD) in people with HIV (PWH). Alterations in tryptophan metabolism through the kynurenine pathway (KP) have also been observed in PWH and are associated with CVD. We aimed to explore relationships between KP metabolites and inflammatory profiles of PWH. Methods In the…

815 – Readmission Risk for Adults With HIV Hospitalized for Heart Failure or Acute Myocardial Infarction

Background People with HIV (PWH) have a higher incidence of cardiovascular disease, including heart failure (HF) and acute myocardial infarction (AMI) than people without HIV (PWoH). In the general population, 30-day readmissions following hospitalizations for HF and AMI are common, and reducing these readmissions is a national quality of care priority. This study compares the 30-day…